Rare diseases
Investigational molecules
Locations
Back to Romania55 clinical trials in Sibiu, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis
RomaniaStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
RomaniaStudy on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections
RomaniaRomaniaStudy on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17
RomaniaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
RomaniaPhase 1/2 Study of pumitamig Alone or Combined with ipilimumab or cabozantinib in Patients with Advanced Renal Cell Carcinoma
RomaniaSafety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE
RomaniaEfficacy of Etifoxine in Adults with Adjustment Disorder with Anxiety: A Randomized, Double‑Blind, Placebo‑Controlled Trial
RomaniaStudy on Cefepime and Enmetazobactam for Children with Complicated Urinary Tract Infections, Including Acute Pyelonephritis
RomaniaOral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type
RomaniaEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on Myasthenia Gravis and various forms of Multiple Sclerosis, including studies evaluating new therapeutic approaches for disease management and symptom control.
Several trials are investigating novel compounds to improve daily living activities and reduce disease progression.
Comprehensive studies on various cancer types, with particular focus on Non-Small Cell Lung Cancer and Lymphoma treatments, including innovative combination therapies.
Advanced therapeutic approaches combining immunotherapy with standard treatments.
Research initiatives addressing Major Depressive Disorder and Schizophrenia, with specialized focus on treatment-resistant cases and cognitive symptoms.
Novel therapeutic approaches targeting specific symptoms and comorbidities.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
